The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.
about
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patientsAntifungal agents for preventing fungal infections in non-neutropenic critically ill patientsSurface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future DirectionsInvasive candidiasis in non neutropenic critically ill - need for region-specific management guidelinesAll you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious diseaseRisk prediction for invasive candidiasisAntifungal chemical compounds identified using a C. elegans pathogenicity assayIdentification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assayEpidemiology of invasive candidiasis: a persistent public health problemSubsurface pressure profiling: a novel mathematical paradigm for computing colony pressures on substrate during fungal infections.Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.A comparison of two sources of data on fungaemia in two hospitals.Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropeniaWeekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.Candida infections of the genitourinary tract.Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicansCaenorhabditis elegans-based model systems for antifungal drug discovery.Risk factors for fluconazole-resistant Candida glabrata bloodstream infectionsUsing C. elegans for antimicrobial drug discovery.Antifungal drug discovery through the study of invertebrate model hosts.Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.Canadian clinical practice guidelines for invasive candidiasis in adults.Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007The epidemiological profile of candidemia at an Indian trauma care centerThe use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis.Economic considerations of antifungal prophylaxis in patients undergoing surgical proceduresEpidemiology of cryptococcal meningitis in the US: 1997-2009.Multilocus sequence typing for analyses of clonality of Candida albicans strains in TaiwanStudy on the effect of neem (Azadirachta indica A. juss) leaf extract on the growth of Aspergillus parasiticus and production of aflatoxin by it at different incubation times.Prevalence of Candida species, including Candida dubliniensis, in Singapore.Pharmacotherapy of Candida bloodstream infections: new treatment options, new era.HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos SantosAttributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approachCaspofungin acetate for treatment of invasive fungal infections.Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.The Toll-like receptors and their role in septic shock.Symptomatic and asymptomatic candidiasis in a pediatric intensive care unitAssociation of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia.
P2860
Q24186457-AB676826-EEEE-4F14-863F-39DB741D4E84Q24244555-6F0127DD-D948-4892-BAB8-4DEC123C2FA4Q24625384-98B107DE-9C41-4D26-921D-AF3D56DCA612Q26771113-F4856CF9-16EA-4C2D-96AF-029C53A06C06Q26801500-2A7F0B89-C78A-41E9-BA36-AB8B7EC2FE03Q26830053-5E8936A2-BC57-4E30-8888-D95D74E12D79Q27023082-D2467DB4-A0E3-4F50-B1A8-EA4FE77A858BQ28469125-14A0667F-AE3C-445B-8493-F2760570FA07Q28476138-B3EF7628-E984-4B5D-8D88-1E8865E4B712Q29616758-6728956E-83B5-4847-8312-C3C0B0BE944AQ30405014-32B1595D-7A7C-474E-B64E-594995CFA6E3Q30994297-2B21E8AF-D78A-496E-B2F1-D1D34B407A84Q31145016-67F3A6CB-2B9D-4E5D-A9DE-2EBC9D58EACCQ33241991-9904250D-348A-4DD2-8DAA-B8272C0B6A95Q33265510-F05DF7E5-AE5F-4D96-959B-609D96487D5EQ33712955-B04C91BA-862D-4008-A562-0FC3D3F23DCAQ33825621-1DB4037C-1F33-451D-A28A-06669D660A5CQ33859372-6E7D5BFD-8F57-4409-A2F1-D8E25170EA4AQ33864072-3BE7E85B-6239-4FB6-99C0-027E67C20737Q33932340-314EB061-35A8-492F-98B6-8BCC2A16982DQ33936475-FEED215D-C7E7-4950-AA1C-4D82DA3B817FQ34002069-A74A867F-A1FF-40DE-8A87-223AC1EF69FCQ34036214-F4EBE546-79EC-4BE4-9587-419C81DFD995Q34237335-336A482C-2B10-4E30-B841-81F6511642EEQ34332272-2EB2C862-1CEF-4B25-867A-737470F9FBCBQ34335391-A11AE62A-B8EB-4479-87EC-7E7F8B1697FDQ34480715-400C866C-AB08-40E1-A141-39974CE8FD24Q34574154-4F6A4247-AFC0-434F-9F70-4B5680712F7FQ34606681-6C2B049F-F8BA-4133-AA31-93B80AFAE11AQ34719660-E900A5CA-F3C3-415A-9774-B36E3FE8748DQ34724824-4AEF233B-2727-42A8-AE38-D4F51CD2796AQ34747519-BD2655B1-61E9-439D-8AF5-A94EC914B861Q34768471-C1673153-5215-4510-ACFB-8980D14DAF55Q34878614-CC8F345B-64A1-4BEE-9FF9-75BCAD957144Q34932560-DBE954F6-3365-4CAA-B2E5-8A49BF57E571Q35035091-1C867B6C-BA61-4E9C-A98F-D32FA3EAED4CQ35487439-CEA9693A-5F65-4CA8-B975-03FA7B235248Q35537894-14ED6110-980F-46B1-B669-AB508820775FQ35582704-BB247CF0-BBF8-458E-AB41-E509DC336F88Q35635693-12E4C4E9-8FD1-4919-BE62-2E51650B5C7A
P2860
The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The impact of candidemia on le ...... , and overall cost of illness.
@ast
The impact of candidemia on le ...... , and overall cost of illness.
@en
The impact of candidemia on le ...... , and overall cost of illness.
@nl
type
label
The impact of candidemia on le ...... , and overall cost of illness.
@ast
The impact of candidemia on le ...... , and overall cost of illness.
@en
The impact of candidemia on le ...... , and overall cost of illness.
@nl
prefLabel
The impact of candidemia on le ...... , and overall cost of illness.
@ast
The impact of candidemia on le ...... , and overall cost of illness.
@en
The impact of candidemia on le ...... , and overall cost of illness.
@nl
P356
P1476
The impact of candidemia on length of hospital stay, outcome, and overall cost of illness
@en
P2093
P304
P356
10.1086/514955
P407
P577
1998-10-01T00:00:00Z